Follow
Stephen Wu
Stephen Wu
University of Colorado Anschutz
Verified email at ucdenver.edu
Title
Cited by
Cited by
Year
Platelet bioreactor-on-a-chip
JN Thon, L Mazutis, S Wu, JL Sylman, A Ehrlicher, KR Machlus, Q Feng, ...
Blood, The Journal of the American Society of Hematology 124 (12), 1857-1867, 2014
2292014
Microtubule sliding drives proplatelet elongation and is dependent on cytoplasmic dynein
M Bender, JN Thon, AJ Ehrlicher, S Wu, L Mazutis, E Deschmann, ...
Blood, The Journal of the American Society of Hematology 125 (5), 860-868, 2015
1192015
CCL5 derived from platelets increases megakaryocyte proplatelet formation
KR Machlus, KE Johnson, R Kulenthirarajan, JA Forward, MD Tippy, ...
Blood, The Journal of the American Society of Hematology 127 (7), 921-926, 2016
1112016
Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis
KR Machlus, SK Wu, P Vijey, TS Soussou, ZJ Liu, E Shacham, TJ Unger, ...
Blood, The Journal of the American Society of Hematology 130 (9), 1132-1143, 2017
672017
Evaluating TBK1 as a therapeutic target in cancers with activated IRF3
A Muvaffak, Q Pan, H Yan, R Fernandez, J Lim, B Dolinski, TT Nguyen, ...
Molecular Cancer Research 12 (7), 1055-1066, 2014
582014
Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation
KR Machlus, SK Wu, DJ Stumpo, TS Soussou, DS Paul, RA Campbell, ...
Blood, The Journal of the American Society of Hematology 127 (11), 1468-1480, 2016
402016
480 Identification of novel small molecules as selective PAK4 allosteric modulators (PAMs) by stable isotope labeling of amino acids in cells (SILAC)
W Senapedis, Y Landesman, M Schenone, B Karger, S Wu, S Shacham, ...
European Journal of Cancer, 156, 2014
32014
Activity of Selinexor As a Single Agent and Synergistic Activity with Approved/Investigational Myelofibrosis Therapies in Vitro
MEE Maloof, S Wu, A Ellero, CJ Walker, S Kye, P Taverna
Blood 142, 6353, 2023
12023
CCL5 Released from platelets increases megakaryocyte maturation and proplatelet formation
KR Machlus, KE Johnson, R Kulenthirarajan, S El-Husayni, JA Forward, ...
Blood 126 (23), 1162, 2015
12015
Selinexor-induced thrombocytopenia results from the inhibition of megakaryocyte progenitor cells in the early stage of megakaryopoiesis
KR Machlus, S Wu, R Carlson, S Friedlander, T Kashyap, O Kalid, ...
Blood 124 (21), 1458, 2014
12014
Selinexor Disrupts Epigenetic Programing and Modulates Immunogenicity in Multiple Myeloma
PR Sudalagunta, R Renatino-Canevarolo, MB Meads, D Noyes, A Achille, ...
Blood 142, 3301, 2023
2023
Synthesis of marcks in the late stages of megakaryocyte maturation drives proplatelet formation
K Machlus, SK Wu, DJ Stumpo, RA Campbell, AS Weyrich, PJ Blackshear, ...
JOURNAL OF THROMBOSIS AND HAEMOSTASIS 13, 126-126, 2015
2015
Dynein-dependent microtubule sliding drives proplatelet elongation
M Bender, JN Thon, AJ Ehrlicher, S Wu, L Mazutis, E Deschmann, ...
JOURNAL OF THROMBOSIS AND HAEMOSTASIS 13, 184-184, 2015
2015
Evaluating TBK1 as a cancer therapeutic target in cancer cell lines with activated IRF3.
A Muvaffak, Q Pan, R Middleton, E Morris, R Fernandez, J Lim, B Dolinski, ...
Cancer Research 73 (8_Supplement), 4372-4372, 2013
2013
Scientific Category: Platelets and Thrombopoiesis Article title: Microtubule sliding drives proplatelet elongation and is dependent on cytoplasmic dynein
M Bender, JN Thon, AJ Ehrlicher, S Wu, L Mazutis, E Deschmann, ...
The system can't perform the operation now. Try again later.
Articles 1–15